A
Amphastar Pharmaceuticals, Inc.
AMPH · NASDAQ · Healthcare · 922M
Closing price
$26.62
+3.14% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
12.7×
Price / net assetsP/B
1.6×
Enterprise value / EBITDAEV/EBITDA
8.1×
Free cash flow yieldFCF yield
9.7%
Return on equityROE
12.4%
Operating margin
19.5%
Net debt / EBITDAbalance-sheet strength
2.3×
Interest coverage
5.5×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.